Originally posted by kmcarr
View Post
Unconfigured Ad
Collapse
X
-
Nope - You've misinterpreted the paper. It doesn't actually say that - it says that using the USS alone is problematic - but the combination of USS and STL is not.
-
I stand by my statements. USS would be problematic if duplicate removal was standard practice for RNA-Seq data. It is not.Originally posted by cement_head View PostNope - You've misinterpreted the paper. It doesn't actually say that - it says that using the USS alone is problematic - but the combination of USS and STL is not.
Second, they failed to present any data demonstrating significant levels of PCR duplication in the data in the first place. What is needed in Fig. 5 is a curve plotting number of reads mapped for each of the 24 ERCC controls or mRNAs with out first doing any de-duplication by either USS alone or USS+STL. Only if that curve was significantly higher than the USS+STL curve (blue line in Fig. 5) could they make for adding molecular indexes to RNA-Seq libraries.
What the white paper is attempting to do is to sell a solution without first demonstrating a problem which needs solving.
Comment
-
I believe you are incorrect. Despite the assumption that any fragment that is identical with respect to USS is likely a PCR duplicate, it turns out that this is not the case. Not removing true duplicates would misrepresent (overestimate) the original (pre-PCR) molecule population in the biological sample. If you are not removing duplicates in an RNA-Seq analysis, then you are relying on statistical tests to de facto do so during the analyses stages - especially in the cases of DGE experiments. The approach of using molecular indices (STLs) in combination with USSs clarifies which of the fragments is PCR artefact based and which fragments were originally present in the biological sample.Originally posted by kmcarr View PostI stand by my statements. USS would be problematic if duplicate removal was standard practice for RNA-Seq data. It is not.
Second, they failed to present any data demonstrating significant levels of PCR duplication in the data in the first place. What is needed in Fig. 5 is a curve plotting number of reads mapped for each of the 24 ERCC controls or mRNAs with out first doing any de-duplication by either USS alone or USS+STL. Only if that curve was significantly higher than the USS+STL curve (blue line in Fig. 5) could they make for adding molecular indexes to RNA-Seq libraries.
What the white paper is attempting to do is to sell a solution without first demonstrating a problem which needs solving.
Here is a link to example data that demonstrates the difference between USS usage and USS + STLs usage: http://www.biooscientific.com/Portal...lar-Labels.pdf
I hope this clears up your queries.
Regards,
Andor
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Genome Sequencing Reveals Large, Repeat-Rich DNA in Trapdoor Spider Named for Stephen Colbert
by SEQadmin2
Started by SEQadmin2, 10-28-2026, 09:57 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:57 AM
|
||
|
Started by SEQadmin2, 10-28-2026, 09:51 AM
|
0 responses
14 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:51 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
67 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
47 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
Comment